Safety, Pharmacokinetics, and Immunogenicity of the Combination of the Broadly Neutralizing Anti-Hiv-1 Antibodies 3BNC117 and 10-1074 in Healthy Adults: A Randomized, Phase 1 Study
PLoS ONE - United States
doi 10.1371/journal.pone.0219142
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 8, 2019
Authors
Publisher
Public Library of Science (PLoS)